Lexicon Pharmaceuticals (LXRX) PT Raised to $6 at Stifel

March 11, 2021 8:47 AM EST Send to a Friend

Stifel analyst Stephen D. Willey ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Lexicon Pharmaceuticals (LXRX) PT Raised to $6 at Stifel

Member Login

Free News Feed